Real-World Use of Diabetes Technology and Associated Clinical Outcomes in People With Type 1 Diabetes: The Kyoto T1D-TECH Registry

Real-World Use of Diabetes Technology and Associated Clinical Outcomes in People With Type 1 Diabetes: The Kyoto T1D-TECH Registry - The Kyoto T1D-TECH Registry

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061435

Enrollment

300

Registered

2026-05-01

Start date

2026-04-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age 4 years or older Diagnosis of type 1 diabetes mellitus (T1DM)

Exclusion criteria

Exclusion criteria: Age < 4 years Participants considered unsuitable for participation in this study by the principal investigator or sub-investigators

Design outcomes

Primary

Measure	Time frame
The primary objective of this study was to clarify the real-world use of diabetes technologies in individuals with type 1 diabetes, including continuous glucose monitoring (CGM), continuous subcutaneous insulin infusion (CSII), and automated insulin delivery (AID) systems, and to examine their associations with glycemic metrics such as glycated hemoglobin (HbA1c) and time in range (TIR), as well as clinical outcomes.	—

Measure

Time frame

The primary objective of this study was to clarify the real-world use of diabetes technologies in individuals with type 1 diabetes, including continuous glucose monitoring (CGM), continuous subcutaneous insulin infusion (CSII), and automated insulin delivery (AID) systems, and to examine their associations with glycemic metrics such as glycated hemoglobin (HbA1c) and time in range (TIR), as well as clinical outcomes.

—

Countries

Japan

Contacts

Public ContactSakane Naoki

National Hospital Organization Kyoto Medical Center Clinical Research Institute

404-j-doit1@mail.hosp.go.jp0756419161

Outcome results